Patents by Inventor Christophe PELLEFIGUES

Christophe PELLEFIGUES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
    Publication number: 20230330062
    Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.
    Type: Application
    Filed: December 20, 2022
    Publication date: October 19, 2023
    Inventors: Nicolas CHARLES, Christophe PELLEFIGUES
  • PTGDR-1 and/or PTGDR-2 antagonists for preventing and/or treating systemic lupus erythematosus
    Patent number: 11559513
    Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: January 24, 2023
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS CITE
    Inventors: Nicolas Charles, Christophe Pellefigues
  • PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
    Publication number: 20200261413
    Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.
    Type: Application
    Filed: April 13, 2020
    Publication date: August 20, 2020
    Inventors: Nicolas CHARLES, Christophe PELLEFIGUES
  • PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
    Publication number: 20180296528
    Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.
    Type: Application
    Filed: June 19, 2018
    Publication date: October 18, 2018
    Inventors: Nicolas CHARLES, Christophe PELLEFIGUES
  • PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
    Publication number: 20180021302
    Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.
    Type: Application
    Filed: February 12, 2016
    Publication date: January 25, 2018
    Inventors: Nicolas CHARLES, Christophe PELLEFIGUES